These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G. Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650 [TBL] [Abstract][Full Text] [Related]
4. Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F. Siu KK; Sultana A; Azimi FC; Lee JE Nat Commun; 2013; 4():2593. PubMed ID: 24185281 [TBL] [Abstract][Full Text] [Related]
5. Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F. Albin JS; Anderson JS; Johnson JR; Harjes E; Matsuo H; Krogan NJ; Harris RS J Mol Biol; 2013 Apr; 425(7):1172-82. PubMed ID: 23318957 [TBL] [Abstract][Full Text] [Related]
6. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. He Z; Zhang W; Chen G; Xu R; Yu XF J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467 [TBL] [Abstract][Full Text] [Related]
7. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. Russell RA; Smith J; Barr R; Bhattacharyya D; Pathak VK J Virol; 2009 Feb; 83(4):1992-2003. PubMed ID: 19036809 [TBL] [Abstract][Full Text] [Related]
8. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. Albin JS; LaRue RS; Weaver JA; Brown WL; Shindo K; Harjes E; Matsuo H; Harris RS J Biol Chem; 2010 Dec; 285(52):40785-92. PubMed ID: 20971849 [TBL] [Abstract][Full Text] [Related]
9. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. Dang Y; Wang X; York IA; Zheng YH J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083 [TBL] [Abstract][Full Text] [Related]
10. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. Binka M; Ooms M; Steward M; Simon V J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041 [TBL] [Abstract][Full Text] [Related]
11. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity. Dang Y; Davis RW; York IA; Zheng YH J Virol; 2010 Jun; 84(11):5741-50. PubMed ID: 20335268 [TBL] [Abstract][Full Text] [Related]
13. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. Smith JL; Pathak VK J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965 [TBL] [Abstract][Full Text] [Related]
14. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins. Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851 [TBL] [Abstract][Full Text] [Related]
15. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. Russell RA; Pathak VK J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216 [TBL] [Abstract][Full Text] [Related]
16. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124 [TBL] [Abstract][Full Text] [Related]
17. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. Kitamura S; Ode H; Nakashima M; Imahashi M; Naganawa Y; Kurosawa T; Yokomaku Y; Yamane T; Watanabe N; Suzuki A; Sugiura W; Iwatani Y Nat Struct Mol Biol; 2012 Oct; 19(10):1005-10. PubMed ID: 23001005 [TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism. Marin M; Golem S; Rose KM; Kozak SL; Kabat D J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970 [TBL] [Abstract][Full Text] [Related]
19. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. Albin JS; Brown WL; Harris RS Virology; 2014 Feb; 450-451():49-54. PubMed ID: 24503066 [TBL] [Abstract][Full Text] [Related]
20. Structural basis of antagonism of human APOBEC3F by HIV-1 Vif. Hu Y; Desimmie BA; Nguyen HC; Ziegler SJ; Cheng TC; Chen J; Wang J; Wang H; Zhang K; Pathak VK; Xiong Y Nat Struct Mol Biol; 2019 Dec; 26(12):1176-1183. PubMed ID: 31792451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]